How One Biotech Company Is Accelerating The Drug Discovery Workflow

Drug discovery is evolving rapidly, and companies must navigate increasingly complex workflows to bring therapies to market faster and more efficiently. Cytiva is helping lead this transformation, not just by supplying tools, but by anticipating industry needs before they arise. From miniaturized technologies that preserve precious samples to AI-powered data lakes that accelerate decision-making, Cytiva’s innovations are reshaping how biopharma companies approach discovery and development. A compelling example is its collaboration with Nuclera, which integrates protein expression and characterization into a single streamlined workflow, cutting timelines from months to days. These advances aren’t just technical—they’re deeply human, as illustrated by a chance encounter that reminded one scientist of the life-changing impact of his work.

Access the full article for a deeper look into how Cytiva is helping redefine the future of therapeutics.